SUBSCRIBE
SUBSCRIBE

Postmarket research

Drug Development
Viagra Boosts Feel-Good “Love” Hormone: Study
August 24, 2007
 · 
1 min read
Drug Development
Celecoxib Helps Prevent Restenosis And Appears Safe
August 23, 2007
 · 
1 min read
Drug Development
Genetics Determine Optimal Drug Dose of Common Anticoagulant
August 22, 2007
 · 
1 min read
Drug Development
South African Study Backs Drugs over Food Against HIV
August 22, 2007
 · 
1 min read
Drug Development
Genetics Determine Optimal Drug Dose of Common Anticoagulant, American Society of Hematology Study
August 21, 2007
 · 
3 min read
Drug Development
Drug For Cluster Headaches May Cause Heart Problems
August 20, 2007
 · 
1 min read
Drug Development
Zolmitriptan Nasal Spray Effective for Adolescent Migraine
August 20, 2007
 · 
1 min read
Drug Development
Celecoxib Cuts Paclitaxel-Eluting Stent Restenosis Rate
August 20, 2007
 · 
1 min read
Drug Development
No Proof Zinc Lozenges Help Cold Symptoms
August 17, 2007
 · 
1 min read
Drug Development
U.S. Orders Genetic Data on Blood-Thinner Risks
August 17, 2007
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Amylin Pharmaceuticals, Inc. Study Finds BYETTA(R) Use Was Not Associated With Increased Rate of Acute Pancreatitis Compared to Other Antidiabetic Drugs: Final Results Presented at American Diabetes Association 2010
June 28, 2010
 · 
9 min read
Drug Development
Daiichi Sankyo, Inc. New Data Demonstrated Efficacy and Safety of Initial Combination Therapy with Welchol(R) (colesevelam HCl) and Metformin in Drug-Naive Adult Type 2 Diabetes Patients
June 28, 2010
 · 
11 min read
Drug Development
Biodel Inc. Studies Demonstrate Potential Benefits of More-Rapid-Acting Injectable Insulins: Poster Presentations at Annual Meeting of the American Diabetes Association
June 28, 2010
 · 
6 min read
Drug Development
Amylin Pharmaceuticals, Inc.: BYDUREON(TM) Safety and Tolerability Pooled Summary Data Presented at American Diabetes Association 2010
June 28, 2010
 · 
11 min read
Drug Development
Amylin Pharmaceuticals, Inc.: Type 2 Diabetes Patients With Long-Standing Disease Achieved Glycemic Control When BYETTA(R) Was Added to Lantus(R)
June 28, 2010
 · 
9 min read
Drug Development
Orexigen Therapeutics, Inc. Presents New Data Showing Contrave(R) Significantly Lowers Weight, Improves Blood Glucose Control in Obese Patients With Type 2 Diabetes
June 28, 2010
 · 
7 min read
Drug Development
Two New Studies Cite Heart Risk in GlaxoSmithKline’s Avandia
June 28, 2010
 · 
1 min read
Drug Development
Sanofi-Aventis (France): Improved Outcomes for Patients Treated with Lantus(R) and Apidra(R) Regimen Compared with Sliding Scale Insulin
June 28, 2010
 · 
6 min read
Drug Development
Shire Pharmaceuticals Braced for US Study into Heart Risks of Attention Deficit Drug
June 28, 2010
 · 
1 min read
Drug Development
Novo Nordisk A/S Says Victoza Tops Januvia for Weight Loss
June 28, 2010
 · 
7 min read
Drug Development
Gilead Sciences, Inc. Head-to-Head Study of Cayston(R) Versus Tobramycin Inhalation Solution in Cystic Fibrosis Patients Achieves Co-Primary Efficacy Endpoint of Non-Inferiority
June 18, 2010
 · 
1 min read
Drug Development
UCB Group’s Neupro(R) (Rotigotine) Significantly Improved Wellbeing And Daily Activities Impaired Due To Limb Pain Associated With Restless Legs Syndrome
June 18, 2010
 · 
14 min read
Drug Development
UCB, Inc.'s Neupro(R) (Rotigotine Transdermal System) Significantly Improved Wellbeing and Daily Activities Impaired Due to Limb Pain Associated With Restless Legs Syndrome
June 18, 2010
 · 
12 min read
Drug Development
Amylin Pharmaceuticals, Inc. to Present New Data and Insights From the Company’s Diabetes
June 18, 2010
 · 
11 min read
Drug Development
UCB, Inc.: Neupro(R) (rotigotine transdermal system) Showed Significant Benefit on Early Morning Motor Control, Sleep and Nocturnal Symptoms in Patients With Parkinson’s Disease
June 17, 2010
 · 
10 min read
Drug Development
Pfizer Inc.'s Celebrex Causes Less Stomach Upset, Bleeding
June 17, 2010
 · 
6 min read
Drug Development
UCB Group Long-term Cimzia(R) (certolizumab pegol) Data Demonstrated Rapid Sustained Improvements in Clinical Outcomes and Quality of Life in Moderate to Severe Rheumatoid Arthritis (RA) Patients
June 16, 2010
 · 
14 min read
Drug Development
Alkermes Release: DURATION-4 Study Results: BYDUREON Efficacy and Tolerability Profile Extended to Monotherapy Treatment
June 15, 2010
 · 
10 min read
Drug Development
Amylin Pharmaceuticals, Inc. Release: DURATION-4 Study Results: BYDUREON(TM) Efficacy and Tolerability Profile Extended to Monotherapy Treatment
June 15, 2010
 · 
1 min read
Drug Development
Alexion Pharmaceuticals Inc. Release: Early Clinical Experience and Basic Science Support Further Investigation of Soliris(R) (eculizumab) for the Treatment of Patients with Thrombotic Microangiopathy
June 15, 2010
 · 
1 min read
Load More